Showing results (391-400 of 2,229) with videos related to
Sort By:
Pageof 223
Cancer Biotherapy & Radiopharmaceuticals|July 21, 2021
miR-193a-3p Enhanced the Chemosensitivity to Trametinib in Gallbladder Carcinoma by Targeting KRAS and Downregulating ERK SignalingGanghua Yang, Qinhong Xu, Yong Wan, et al.Cancer Biotherapy & Radiopharmaceuticals|May 25, 2022
Screening and Preclinical Evaluation of Novel Radiolabeled Anti-Fibroblast Activation Protein-α Recombinant AntibodiesJianfeng Xu, Shenghua Li, Shasha Xu, et al.Cancer Biotherapy & Radiopharmaceuticals|May 20, 2022
Estimation of Cumulative Activity of 177Lu-Cetuximab from a Single Diagnostic 64Cu-Cetuximab ScanEric Laffon, Roger MarthanCancer Biotherapy & Radiopharmaceuticals|June 29, 2021
A Whole-Body Physiologically Based Pharmacokinetic Model for Alpha Particle Emitting Bismuth in RatsNouran R R Zaid, Peter Kletting, Gordon Winter, et al.Cancer Biotherapy & Radiopharmaceuticals|June 2, 2021
The Efficacy of Hemoglobin, Albumin, Lymphocytes, and Platelets as a Prognostic Marker for Survival in Octogenarians and Nonagenarians Undergoing Colorectal Cancer SurgeryHasan Dagmura, Emin Daldal, Ismail OkanCancer Biotherapy & Radiopharmaceuticals|March 18, 2020
Preclinical Single Photon Emission Computed Tomography of Alpha Particle-Emitting Radium-223Diane S Abou, Andrew Rittenbach, Ryan E Tomlinson, et al.Cancer Biotherapy & Radiopharmaceuticals|March 11, 2020
lncRNA HAND2-AS1 Inhibits Liver Cancer Cell Proliferation and Migration by Upregulating SOCS5 to Inactivate the JAK-STAT PathwayDaojie Yan, Fengwei Jin, Yufeng LinCancer Biotherapy & Radiopharmaceuticals|March 21, 2020
Comparative In Vitro Cytotoxicity Studies of 177Lu-CHX-A″-DTPA-Trastuzumab and 177Lu-CHX-A″-DTPA-F(ab')2-Trastuzumab in HER2-Positive Cancer Cell LinesRohit Sharma, Mythili Kameswaran, Ashutosh DashCancer Biotherapy & Radiopharmaceuticals|September 30, 2020
Sevoflurane Suppresses Glioma Cell Proliferation, Migration, and Invasion Both In Vitro and In Vivo Partially Via Regulating KCNQ1OT1/miR-146b-5p/STC1 AxisJian Wen, Yan Ding, Shaohua Zheng, et al.Cancer Biotherapy & Radiopharmaceuticals|September 30, 2020
Nanoparticle-Based Radiosensitizers in Radiotherapy ApplicationsYasemin Benderli CihanPageof 223